It's important to consider your comfort with risk before diving in.

Biotech stocks are considered extremely high-risk, high-reward investments. Many biotech companies are developing one or more ...

Two biotech innovators, two very different risk profiles: one with commercial products and another betting on next-gen gene editing breakthroughs.

Shares of Puma Biotechnology PBYI have witnessed a sharp increase in the past three months, driven by investor optimism ...

New drug approvals and encouraging pipeline progress should maintain momentum in the Zacks Biomedical and Genetics industry ...

Shares Nasdaq Biotechnology ETF is rated a Hold with modest valuation but lackluster momentum and unfavorable market themes.

In 2025, biotechnology stocks had their best year since the COVID-19 pandemic, with the market sector’s two major indexes — the SDPR S&P Biotech ETX (NYSE: XBI) and iShares Biotech ETF (NYSE: IBB) — ...

Viking stock is known for soaring after positive news.

Biogen has recently outperformed its industry peers, and analysts remain reasonably upbeat about the stock’s prospects.